By Mill Chart
Last update: Sep 26, 2023
Groth investors are looking for stocks showing high revenue and EPS growth. We will have a look here to see if STAAR SURGICAL CO (NASDAQ:STAA) is suited for growth investing, while it is forming a base and may be ready to breakout. Investors should of course do their own research, but we spotted STAAR SURGICAL CO showing up in our growth with base formation screen, so it may be worth spending some more time on it.
ChartMill employs its own Growth Rating system for all stocks. This score, ranging from 0 to 10, is derived by evaluating different growth factors, such as EPS and revenue growth, taking into account both past performance and future projections. NASDAQ:STAA has earned a 8 for growth:
ChartMill assigns a Health Rating to every stock. This score ranges from 0 to 10 and evaluates the different health aspects like liquidity and solvency, both absolutely, but also relative to the industry peers. NASDAQ:STAA scores a 6 out of 10:
ChartMill assigns a proprietary Profitability Rating to each stock. The score is computed by evaluating various profitability ratios and margins and ranges from 0 to 10. NASDAQ:STAA was assigned a score of 8 for profitability:
Next to the Technical Rating, the Setup Rating of a stock determines to which extend the stock is consolidating. This score also ranges from 0 to 10 and is updated daily. The setup score evaluates various short term technical indicators. For NASDAQ:STAA this score is currently 8:
Although the technical rating is bad, STAA does present a nice setup opportunity. We see reduced volatility while prices have been consolidating in the most recent period. We notice that large players showed an interest for STAA in the last couple of days, which is a good sign.
More Strong Growth stocks can be found in our Strong Growth screener.
Our latest full fundamental report of STAA contains the most current fundamental analsysis.
Check the latest full technical report of STAA for a complete technical analysis.
This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.
STAAR SURGICAL CO
NASDAQ:STAA (4/22/2024, 7:00:01 PM)
After market: 46.55 0 (0%)46.55
+0.16 (+0.34%)
The company makes an implantable lens to help correct vision problems.
These three alternatives to Nvidia stock combined are smaller than the chipmaker but are worth it when considering Nvidia's market cap.